Z+PHARMA
The computed 12-month bankruptcy probability of Z+PHARMA is 0.4% (very low). The company has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 32 yrs |
| Locations | 1 |
| Publications | 2 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-03-2025 | verkort | 24-09-2025 | 2025-00502098 |
| 31-03-2024 | verkort | 29-10-2024 | 2024-00519124 |
| 31-12-2022 | verkort | 26-05-2023 | 2023-00099349 |
| 31-12-2021 | verkort | 30-05-2022 | 2022-20041416 |
| 31-12-2020 | verkort | 05-08-2021 | 2021-46300352 |
| 31-12-2019 | verkort | 28-05-2020 | 2020-14100252 |
| 31-12-2018 | verkort | 06-08-2019 | 2019-43700062 |
| 31-12-2017 | verkort | 26-07-2018 | 2018-37500372 |
| 31-12-2016 | verkort | 29-08-2017 | 2017-49100203 |
| 31-12-2015 | verkort | 27-08-2016 | 2016-48000297 |
| NACE primary | Retail trade(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 01-07-1994 |
| Status | Active |
| Postal code | 2070 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11056B0771/00V003 | Flanders | 559 m² | 1 · 199 m² | 10.2 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
06-12-2024 Transaction in capital or shares
Technical details
{
"events": [
{
"kind": "vzw_capital_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Willem Muyshondt",
"firm_city": null,
"firm_name": null,
"office_city": "Halle",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-12-06",
"filing_date": "2024-12-04",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-06-28",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-06-26"
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": "EY Bedrijfsrevisoren",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Emilie VAN CALLEMONT"
},
"subject_company": {
"kbo": "0453.060.967",
"name_full": "Z\u002BPHARMA",
"legal_form": "Besloten Vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 750,
"class_name": "Aandelen met stemrecht",
"capital_share_eur": 61500.0,
"voting_rights_per_share": 1.0
}
]
}18-11-2024 EY Bedrijfsrevisoren appointed as statutory auditor
- EY Bedrijfsrevisoren, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "EY Bedrijfsrevisoren",
"address": "1831 Diegem, Kouterveldstraat 7B Bus 001",
"birth_date": null,
"profession": "bedrijfsrevisor",
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "1. benoeming van de commissaris De enige Aandeelhouder besluit te benoemen als commissaris van de Vennootschap, met ingang van het boekjaar eindigend op 31 maart 2025, de besloten vennootschap \u0022EY Bedrijfsrevisoren\u0022, met zetel te 1831 Diegem, Kouterveldstraat 7B Bus 001, RPR Brussel en met BTW-numme",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "4. Het verlenen van een volmacht. De vergadering verleent, voor zoveel als nodig, bijzondere volmacht aan de heer Mathias AERTSEN en mevrouw Juna JACQUEMIN, en iedere andere medewerker van de Vennootschap of een daarmee verbonden vennootschap in de zin van artikel 1:20 WVV, om, individueel bevoegd e",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-11-18",
"filing_date": "2024-11-04",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-06-26",
"unanimous": true
},
{
"body": "bijzondere_algemene_vergadering",
"date": "2024-06-26",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0453.060.967",
"name_full": "Z\u002BPharma",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Mathias Aertsen",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Z+PHARMA |